Medra
PrivateLast Round
Series A
Dec 11, 2025
Total Funding Raised
$63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Medra operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in December 2025.
Medra is a biotechnology company that develops autonomous robotic systems and artificial intelligence platforms to automate laboratory experiments and accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Industrial Robotics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medra Comparables
Compare Medra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strateos | 84% | |
| Tetsuwan Scientific | 82% | |
| Reshape Biotech | 81% |
For institutional investors. Book with your work email.
Medra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 11, 2025 | ||||
| Seed | Sep 11, 2025 | ||||
| Accelerator | Dec 5, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series A |
| Neo | Series A, Seed |
| Fusion Fund | Series A |
| PharmStars | Accelerator |
| Lux Capital | Series A, Seed |
| Seven Seven Six | Series A |
| Catalio Capital Management | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 19, 2026
Grew 28% QoQ, from 57 to 73 employees.
- Jul 28, 2026
Grew 66% QoQ, from 41 to 68 employees.
For institutional investors. Book with your work email.
Medra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medra's valuation, stock price, and market status.
Is Medra a public or private company?
Medra is a private company.
What is the current stock price of Medra?
Medra is a private company, so its shares have no public market price. Caplight tracks Medra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medra worth (valuation)?
Valuation information for Medra is not publicly available.
Can I buy Medra stock?
Medra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medra's last funding round?
Medra's most recent funding round was Series A on December 11, 2025.
Who are the main investors in Medra?
Key investors in Medra include Human Capital, Neo, Lux Capital.
Will Medra IPO soon?
No public IPO plans have been announced for Medra.
How can I track Medra secondary market activity?
Caplight tracks bids, offers, and trades in Medra's shares on secondary markets.